SNGXSOLIGENIX, INC.

Nasdaq www.soligenix.com


$ 6.03 $ -0.32 (-5.01 %)    

Friday, 19-Jul-2024 14:19:49 EDT
QQQ $ 475.02 $ -4.25 (-0.89 %)
DIA $ 402.92 $ -3.77 (-0.93 %)
SPY $ 548.99 $ -3.67 (-0.66 %)
TLT $ 92.97 $ -0.55 (-0.59 %)
GLD $ 221.79 $ -4.05 (-1.79 %)
$ 6.07
$ 6.59
$ 0.00 x 0
$ 0.00 x 0
$ 5.86 - $ 6.59
$ 1.83 - $ 32.00
241,725
na
3.99M
$ 0.76
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-10-2024 03-31-2024 10-Q
2 03-15-2024 12-31-2023 10-K
3 11-13-2023 09-30-2023 10-Q
4 08-21-2023 06-30-2023 10-Q
5 05-15-2023 03-31-2023 10-Q
6 03-31-2023 12-31-2022 10-K
7 11-10-2022 09-30-2022 10-Q
8 08-12-2022 06-30-2022 10-Q
9 05-13-2022 03-31-2022 10-Q
10 03-29-2022 12-31-2021 10-K
11 11-12-2021 09-30-2021 10-Q
12 08-13-2021 06-30-2021 10-Q
13 05-18-2021 03-31-2021 10-Q
14 03-30-2021 12-31-2020 10-K
15 11-12-2020 09-30-2020 10-Q
16 08-14-2020 06-30-2020 10-Q
17 05-15-2020 03-31-2020 10-Q
18 03-30-2020 12-31-2019 10-K
19 11-12-2019 09-30-2019 10-Q
20 08-13-2019 06-30-2019 10-Q
21 05-14-2019 03-31-2019 10-Q
22 03-26-2019 12-31-2018 10-K
23 11-09-2018 09-30-2018 10-Q
24 08-08-2018 06-30-2018 10-Q
25 05-11-2018 03-31-2018 10-Q
26 03-15-2018 12-31-2017 10-K
27 11-06-2017 09-30-2017 10-Q
28 08-11-2017 06-30-2017 10-Q
29 05-11-2017 03-31-2017 10-Q
30 03-27-2017 12-31-2016 10-K
31 11-10-2016 09-30-2016 10-Q
32 08-11-2016 06-30-2016 10-Q
33 05-12-2016 03-31-2016 10-Q
34 03-24-2016 12-31-2015 10-K
35 11-12-2015 09-30-2015 10-Q
36 08-12-2015 06-30-2015 10-Q
37 05-14-2015 03-31-2015 10-Q
38 03-25-2015 12-31-2014 10-K
39 11-10-2014 09-30-2014 10-Q
40 08-11-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 nano-cap-soligenix-stock-surges-over-200-on-tuesday-heres-why

Soligenix shares surged on heavy volume, following an interim update on the extended Hybryte treatment study.

 soligenix-shares-resume-trade
Soligenix Shares Resume Trade
07/09/2024 13:57:06

Core News & Articles
Market-Moving News for July 9th
07/09/2024 12:29:07

SNGX: 142% | Soligenix shares are trading higher after the company announced interim results for extended HyBryte treatment in ...

 soligenix-announces-hybryte-treatment-results-in-early-stage-cutaneous-t-cell-lymphoma

"In the Phase 3 FLASH study, HyBryte™ was shown to be efficacious with a promising safety profile. With limited treatment o...

 soligenix-announces-interim-results-for-extended-hybryte-treatment-in-early-stage-ctcl-patients

Soligenix, Inc. (NASDAQ:SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and comm...

 watching-soligenix-zacks-small-cap-research-gives-stock-32-price-valuation-says-model-is-highly-dependent-upon-continued-clinical-success-of-the-companys-pipeline-and-will-be-adjusted-accordingly-based-upon-future-clinical-results

https://s27.q4cdn.com/906368049/files/News/2024/Zacks_SCR_Research_06142024_SNGX_Bautz.pdf

 soligenix-has-filed-a-new-patent-application-titled-compositions-and-methods-of-manufacturing-trivalent-filovirus-vaccines

https://ppubs.uspto.gov/pubwebapp/external.html?q=(20240189413).pn